Modern Pharmaceutical To Acquire Shanghai Institute Of Pharmaceutical Industry
This article was originally published in PharmAsia News
Shanghai Modern Pharmaceutical plans to acquire the stake of its biggest shareholder,Shanghai Institute of Pharmaceutical Industry. As one of the three largest state-owned listed companies in the pharmaceutical sector, Modern Pharmaceutical will get the equity injection from SIPI in accordance with State-owned Assets Supervision and Administration Commission of the State Council's direction of listing government-owned enterprises. SIPI, one of the most sizable and strongest domestic comprehensive research institutions, looks set to follow this strategy. If the reorganization is successful, Modern Pharmaceutical will become China's first listed state-owned firm, which integrates an academic institution, an industrial base and five national research centers. (Click here for more - Chinese Language)
You may also be interested in...
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Wholesalers are given three more years to set up electronic systems to verify saleable returns under another reprieve from the FDA. Yet the reprieve does not extend to manufacturers, who must respond within 24 hours to wholesalers’ requests to manually verify that a returned product is not suspect.
Agency explains how it will model vaccine authorization process on its licensing process for matters like inspections and lot release.